Full-Time

Associate – Portfolio Analytics

Evergeen

Posted on 9/4/2025

Pantheon Ventures Careers

Pantheon Ventures Careers

201-500 employees

Global private markets investment manager

No salary listed

London, UK

Hybrid

Category
Data & Analytics (3)
, ,
Required Skills
Power BI
Python
Data Science
SQL
Financial analysis
Tableau
Databricks
Snowflake
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • 5+ years' experience in private markets with focus on analytics, portfolio management, or risk
  • Deep exposure to semi-liquid products (40 Act and SICAV and open-ended structures); coupled with direct investment expertise
  • Expertise in return attribution, J-curve analytics, risk-adjusted metrics
  • Ability to translate complex analytics into actionable insights for senior stakeholders
  • Experience in using a diverse analytics toolkit such as Excel, Powerpoint, Tableau/Power BI, Python
  • Bachelor’s degree in Finance, Econometrics, Data Science or related field
  • Financial qualification (CFA, CAIA, FRM, ACA) or working towards one of these qualifications
  • Strong attention to detail, problem solving skills and ability to work and deliver with tight deadlines
  • Innovative and entrepreneurial attitude. Comfortable taking initiative.
  • Excels at clearly and effectively communicating quantitative insights
  • Willing to work in a position with uneven and high priority project work
  • Experience working in financial services, preferably in private markets especially fund of funds structure
  • Understanding of ETL processes and cloud warehouse technologies (Snowflake, Databricks, etc.)
Responsibilities
  • You will perform fund‑ and asset‑level analytics — value driver analysis, portfolio composition analysis, risk-return analysis, market benchmarking. Execute deal‑level attribution and sector analytics to separate market vs. idiosyncratic return drivers.
  • Produce scenario, risk‑concentration and macro‑trend analyses by partnering with Investment, Core Portfolio Management and Research teams.
  • Maintain rolling NAV and cash‑flow projections; feed outputs into pacing, liquidity and volatility reviews by partnering with Core Portfolio Management teams.
  • Help systemise data pipelines (ETL) for analytical dashboards in partnership with Technology and DnA teams.
  • Deliver end‑to‑end single-asset analytics: run back‑testing and forward‑looking NPV/IRR/ROE models, drill into value drivers, scenarios, stress tests, order‑of‑effects and optimal‑exit timing; forecast distribution waterfalls and hedge effectiveness.
  • Power portfolio decisions: supply rolling NAV & cash‑flow projections and post‑mortem analyses versus original underwriting to arm Portfolio Management and Deal teams with data‑driven insights.
Desired Qualifications
  • Experience working in financial services, preferably in private markets especially fund of funds structure
  • Understanding of ETL processes and cloud warehouse technologies (Snowflake, Databricks, etc.)
Pantheon Ventures Careers

Pantheon Ventures Careers

View

Pantheon manages investments in private markets for a broad base of institutional and private clients. It raises and allocates capital to private equity, infrastructure and other private market strategies, offering flagship funds, integrated programs, and customized solutions. The approach uses a global network with offices in multiple major cities to source deals, diversify risk, and tailor investments for each client. Pantheon also oversees listed investment vehicles Pantheon International Plc (PIP) and Pantheon Infrastructure Plc (PINT) on the London Stock Exchange. As of 2022, it reported about $88.9 billion in assets under management and advice, and employed over 460 people worldwide. The goal is to grow client portfolios by providing access to a wide range of private market opportunities across geographies and stages, backed by experienced teams and scalable investment structures.

Company Size

201-500

Company Stage

Private

Total Funding

$379.4M

Headquarters

London, United Kingdom

Founded

1982

Simplify Jobs

Simplify's Take

What believers are saying

  • AI Engineer hiring signals competitive advantage in portfolio analytics and deal sourcing capabilities.
  • eStruxture $1B co-investment positions Pantheon in high-growth Canadian data center infrastructure sector.
  • Career Pathways program and 470-person global team attract top talent in competitive private markets.

What critics are saying

  • AUM stagnant at $88.9B since 2022 despite favorable conditions; fundraising momentum unclear.
  • AMG majority ownership creates succession risk if parent divests or restructures asset management.
  • Infrastructure portfolio faces refinancing pressure as elevated rates compress returns on low-rate acquisitions.

What makes Pantheon Ventures Careers unique

  • Four-decade track record across private equity, infrastructure, and credit across Europe, US, and Asia.
  • Management equity ownership aligns incentives and enables autonomous operations within AMG structure.
  • Listed investment vehicles (PIP, PINT) on London Stock Exchange provide LP liquidity options.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Professional Development Budget

Company News

Benzinga
Mar 18th, 2026
QHP closes $1.1B continuation vehicle for Azurity Pharmaceuticals with HarbourVest

QHP Capital has closed a $1.1 billion continuation vehicle for Azurity Pharmaceuticals, providing liquidity to existing investors whilst securing long-term capital for growth. The transaction was led by HarbourVest Partners, with Pantheon Ventures and Audax Strategic Capital participating. The deal, announced on 13 February 2026, allowed limited partners in QHP's selling fund to either take returns or roll proceeds into the continuation vehicle. Strong participation came from existing limited partners, whilst QHP's subsequent fund remains a significant investor. The capital will support Azurity's organic growth, business development, licensing and potential mergers and acquisitions. Azurity is a specialty pharmaceutical company with a portfolio of over 50 medicines spanning 10 therapeutic areas, distributed across more than 50 countries.

Earth Press News
Feb 3rd, 2026
Eurazeo and Pantheon close €480M continuation fund for European private debt assets

Eurazeo, a French investment company managing €37.4 billion in assets, has closed a €480 million private debt continuation vehicle with Pantheon, a global private markets investor. The transaction involves establishing a continuation fund and purchasing a diversified portfolio of high-performing European senior credit assets from Eurazeo's legacy private debt platforms. Under the structure, Eurazeo will continue managing the assets whilst Pantheon provides additional capital, enabling Eurazeo to support medium-sized European businesses. The continuation fund offers liquidity to private investors whilst maintaining underlying asset stability. Nicolas Nedelec, partner of Eurazeo's private debt team, said the transaction demonstrates the strength of their platform and commitment to proactively managing fund lifecycles in investors' best interests.

Curium Pharma
Nov 20th, 2025
CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally - Curium Pharma

Curium and CapVest announce a $7B recapitalization - the largest transaction in nuclear medicine - to accelerate global innovation in diagnostic and therapeutic radiopharmaceuticals.

Bloomberg Law
Jul 16th, 2025
Pantheon Raises $2.2B for Credit Fund

Pantheon raised $2.2 billion for its latest opportunistic credit secondaries fund, nearly tripling its initial target of $750 million. Overall, Pantheon has gathered $8.3 billion in its third fundraising round for senior and opportunistic credit funds. In April, the firm secured $5.2 billion for its flagship credit secondaries fund focused on senior debt. Rakesh Jain, global head of private credit, highlighted this as a validation of market opportunity and their track record.

STT Info
Jun 30th, 2025
Vexve secures €521M for growth

DevCo Partners has secured €521 million in funding to support Vexve's next growth phase. The lead investor is Pantheon, with participation from North American and European family investment firms and institutional investors. About half of the funding comes from Vexve's current investors. The capital will aid Vexve's growth through organic means and acquisitions, driven by the accelerating energy transition.

INACTIVE